Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses.
Benazir SaleemRebecca L RossLesley-Anne BissellAamir AslamKulveer MankiaLaurence DuquenneDiane CorsaddenClive CarterPam HughesFatima A NadatPanji MulipaMark LobbBrendan ClarkeKatie MbaraRuth MortonSophie DibbRahaymin ChowdhuryDarren NewtonAlexandra PikeVishal KakkarSinisia SavicFrancesco DelGaldoPaul EmeryPublished in: RMD open (2022)
Patients with RA on DMARDs have reduced vaccine responses, particularly on certain DMARDs, with improvement on subsequent vaccinations but with approximately 10% still seronegative after three doses.